Abstract
The kidney is a frequent target for organ-specific toxicity as a result of its primary function in controlling body fluids, for example, via resorption of amino acids, peptides, nutrients, ions, xenobiotics and water from the primary urine as well as excretion of metabolic waste products and hydrophilic and amphiphilic xenobiotics. Compounds exhibiting dose-limiting nephrotoxicity include drugs from highly diverse classes and chemical structures, e.g., antibiotics (gentamicin), chemotherapeutics (cisplatin), immunosuppressants (cyclosporine A and tacrolimus) or bisphosphonates (zoledronate). All of these compounds elicit nephrotoxicity primarily by injuring renal proximal tubule epithelial cells (RPTECs). However, prediction of a compound’s nephrotoxic potential in humans to support early unmasking of risk-bearing drug candidates remains an unmet challenge, mainly due to the complex kidney anatomy as well as pronounced inter- and intraspecies differences and lack of relevant and validated human in vitro models. Accordingly, we used the recently established human RPTEC/TERT1 cell line to carry out toxicity studies with a focus on impairment of functional characteristics, i.e., transepithelial electrical resistance (TEER), vectorial transport of water, cations, and anions. Results were compared to real-time cytotoxicity assessments using cellular impedance (xCELLigence assay) and the routine cell viability readout (MTT). As expected, most toxins caused exposure time- and concentration-dependent cytotoxicity. However, for some compounds (cyclosporine A and tacrolimus), transport processes were strongly impaired in absence of a concomitant decrease in cell viability. In conclusion, these data demonstrate that functional parameters are important, highly sensitive and meaningful additional readouts for nephrotoxicity assessment in human renal proximal tubule epithelial cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aschauer L, Carta G, Vogelsang N, Schlatter E, Jennings P (2015a) Expression of xenobiotic transporters in the human renal proximal tubule cell line RPTEC/TERT1. Toxicol In Vitro 30(1 Pt A):95–105. https://doi.org/10.1016/j.tiv.2014.12.003
Aschauer L, Limonciel A, Wilmes A et al (2015b) Application of RPTEC/TERT1 cells for investigation of repeat dose nephrotoxicity: a transcriptomic study. Toxicol In Vitro 30(1 Pt A):106–16. https://doi.org/10.1016/j.tiv.2014.10.005
Asphahani F, Zhang M (2007) Cellular impedance biosensors for drug screening and toxin detection. Analyst 132(9):835–841. https://doi.org/10.1039/b704513a
Duff T, Carter S, Feldman G et al (2002) Transepithelial resistance and inulin permeability as endpoints in in vitro nephrotoxicity testing. Altern Lab Anim 30(Suppl 2):53–59
Gai Z, Visentin M, Hiller C et al (2016) Organic cation transporter 2 overexpression may confer an increased risk of gentamicin-induced nephrotoxicity. Antimicrob Agents Chemother 60(9):5573–5580. https://doi.org/10.1128/AAC.00907-16
Hall AM, Unwin RJ (2007) The not so 'mighty chondrion': emergence of renal diseases due to mitochondrial dysfunction. Nephron Physiol 105(1):p1–10. https://doi.org/10.1159/000096860
Hausherr V, van Thriel C, Krug A, Leist M, Schobel N (2014) Impairment of glutamate signaling in mouse central nervous system neurons in vitro by tri-ortho-cresyl phosphate at noncytotoxic concentrations. Toxicol Sci 142(1):274–284. https://doi.org/10.1093/toxsci/kfu174
Jenkinson SE, Chung GW, van Loon E, Bakar NS, Dalzell AM, Brown CD (2012) The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule. Pflugers Arch 464(6):601–611. https://doi.org/10.1007/s00424-012-1163-2
Lepist EI, Ray AS (2016) Renal transporter-mediated drug-drug interactions: are they clinically relevant? J Clin Pharmacol 56(Suppl 7):S73–81. https://doi.org/10.1002/jcph.735
Lin Z, Will Y (2012) Evaluation of drugs with specific organ toxicities in organ-specific cell lines. Toxicol Sci 126(1):114–127. https://doi.org/10.1093/toxsci/kfr339
Loboz KK, Shenfield GM (2005) Drug combinations and impaired renal function—the 'triple whammy'. Br J Clin Pharmacol 59(2):239–243. https://doi.org/10.1111/j.0306-5251.2004.2188.x
Masereeuw R, Moons MM, Toomey BH, Russel FG, Miller DS (1999) Active lucifer yellow secretion in renal proximal tubule: evidence for organic anion transport system crossover. J Pharmacol Exp Ther 289(2):1104–1111
Miller RP, Tadagavadi RK, Ramesh G, Reeves WB (2010) Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel) 2(11):2490–2518. https://doi.org/10.3390/toxins2112490
Morrissey KM, Stocker SL, Wittwer MB, Xu L, Giacomini KM (2013) Renal transporters in drug development. Annu Rev Pharmacol Toxicol 53:503–529. https://doi.org/10.1146/annurev-pharmtox-011112-140317
Naesens M, Kuypers DR, Sarwal M (2009) Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 4(2):481–508. https://doi.org/10.2215/CJN.04800908
Paueksakon P, Fogo AB (2017) Drug-induced nephropathies. Histopathology 70(1):94–108. https://doi.org/10.1111/his.13064
Pazhayattil GS, Shirali AC (2014) Drug-induced impairment of renal function. Int J Nephrol Renovasc Dis 7:457–468. https://doi.org/10.2147/IJNRD.S39747
Perazella MA, Markowitz GS (2008) Bisphosphonate nephrotoxicity. Kidney Int 74(11):1385–1393. https://doi.org/10.1038/ki.2008.356
Pfaller W, Gstraunthaler G (1998) Nephrotoxicity testing in vitro–what we know and what we need to know. Environ Health Perspect 106(Suppl 2):559–569
Puri S, Folias AE, Hebrok M (2015) Plasticity and dedifferentiation within the pancreas: development, homeostasis, and disease. Cell Stem Cell 16(1):18–31. https://doi.org/10.1016/j.stem.2014.11.001
Quiros Y, Vicente-Vicente L, Morales AI, Lopez-Novoa JM, Lopez-Hernandez FJ (2011) An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin. Toxicol Sci 119(2):245–256. https://doi.org/10.1093/toxsci/kfq267
Sauzay C, White-Koning M, Hennebelle I et al (2016) Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin. Pharmacol Res 110:89–95. https://doi.org/10.1016/j.phrs.2016.05.012
Secker PF, Luks L, Schlichenmaier N, Dietrich DR (2018) RPTEC/TERT1 cells form highly differentiated tubules when cultured in a 3D matrix. Altex 35(2):223–234. https://doi.org/10.14573/altex.1710181
Selen A, Amidon GL, Welling PG (1982) Pharmacokinetics of probenecid following oral doses to human volunteers. J Pharm Sci 71(11):1238–1242
Sepand MR, Ghahremani MH, Razavi-Azarkhiavi K et al (2016) Ellagic acid confers protection against gentamicin-induced oxidative damage, mitochondrial dysfunction and apoptosis-related nephrotoxicity. J Pharm Pharmacol 68(9):1222–1232. https://doi.org/10.1111/jphp.12589
Sirenko O, Grimm FA, Ryan KR et al (2017) In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model. Toxicol Appl Pharmacol 322:60–74. https://doi.org/10.1016/j.taap.2017.02.020
Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ (2015) TEER measurement techniques for in vitro barrier model systems. J Lab Autom 20(2):107–126. https://doi.org/10.1177/2211068214561025
Tiong HY, Huang P, Xiong S, Li Y, Vathsala A, Zink D (2014) Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models. Mol Pharm 11(7):1933–1948. https://doi.org/10.1021/mp400720w
Waring MJ, Arrowsmith J, Leach AR et al (2015) An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat Rev Drug Discov 14(7):475–486. https://doi.org/10.1038/nrd4609
Wenting-Van Wijk MJ, Blankenstein MA, Lafeber FP, Bijlsma JW (1999) Relation of plasma dexamethasone to clinical response. Clin Exp Rheumatol 17(3):305–312
Wieser M, Stadler G, Jennings P et al (2008) hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am J Physiol Renal Physiol 295(5):F1365–F1375. https://doi.org/10.1152/ajprenal.90405.2008
Wilmer MJ, Saleem MA, Masereeuw R et al (2010) Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters. Cell Tissue Res 339(2):449–457. https://doi.org/10.1007/s00441-009-0882-y
Wilmes A, Limonciel A, Aschauer L et al (2013) Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress. J Proteomics 79:180–194. https://doi.org/10.1016/j.jprot.2012.11.022
Wilmes A, Aschauer L, Limonciel A, Pfaller W, Jennings P (2014) Evidence for a role of claudin 2 as a proximal tubular stress responsive paracellular water channel. Toxicol Appl Pharmacol 279(2):163–172. https://doi.org/10.1016/j.taap.2014.05.013
Wilmes A, Bielow C, Ranninger C, et al. (2015) Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics. Toxicol In Vitro 30(1 Pt A):117–27. https://doi.org/10.1016/j.tiv.2014.10.006
Zsengeller ZK, Ellezian L, Brown D et al (2012) Cisplatin nephrotoxicity involves mitochondrial i njury with impaired tubular mitochondrial enzyme activity. J Histochem Cytochem 60(7):521–529. https://doi.org/10.1369/0022155412446227
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Secker, P.F., Schlichenmaier, N., Beilmann, M. et al. Functional transepithelial transport measurements to detect nephrotoxicity in vitro using the RPTEC/TERT1 cell line. Arch Toxicol 93, 1965–1978 (2019). https://doi.org/10.1007/s00204-019-02469-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-019-02469-8